cd19-specific chimeric antigen receptor t cells with pd1 knockout
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2020 (NCT04213469)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04213469 | N/A | Mar 1, 2020 | Central South University, Shanghai Bioray Laboratory Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Central South University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Shanghai Bioray Laboratory Inc. | For profit | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1